Tag Archives: Alzheimer’s Disease

Research Preview: Science Magazine – Jan 23, 2023

Science Magazine – January 13, 2023 issue:

NASA unveils initial plan for multibillion-dollar telescope to find life on alien worlds

Habitable Worlds Observatory would be designed for robotic servicing

Illegal mining has muddied tropical rivers worldwide

Silt overload and mercury pollution endanger river ecosystems—and the people who depend on them

FDA approves new antibody to slow Alzheimer’s disease, even as safety concerns linger

Agency warns about brain swelling and bleeding on drug’s label, but imposes few restrictions on lecanemab’s use

Research Preview: Science Magazine – Dec 9, 2022

Science Magazine – December 9, 2022 issue:

Alzheimer’s drug stirs excitement—and concerns

Antibody slows cognitive decline, but deaths, brain bleeds, and swelling mar results

NASA radar altimetry mission to study hidden ocean swirls

Enhanced resolution of SWOT satellite will highlight how small eddies soak up heat and carbon

Image problems besiege Stanford president

Marc Tessier-Lavigne’s early papers are subject of school and journal investigations

In China, ‘zero COVID’ has become a Catch-2

Population chafes at control measures, but lifting them now would carry huge risks

New U.S. law aims to light up medical research on cannabis

Biden signs bill streamlining pot studies and production

Aging: ‘Healthy Longevity’ Journal – November 2022

Image

Inside the November 2022 Issue:

Research & review on #Alzheimers, global burden of benign prostatic hyperplasia, #WHO def of vitality capacity, IPD meta on social connection &  #cognition#oralhealth for older people & more.


Hope on the horizon for Alzheimer’s disease treatment?

Social connectedness and cognitive decline

Time to take oral health seriously

Fall 2022: ‘Rejuvenating The Aging Brain’ – Scripps Research Magazine Cover

REJUVENATING THE AGING BRAIN

As humans live longer, they’re at increased risk of developing devastating NEURODEGENERATIVE diseases, such as Alzheimer’s—in a treatment landscape with few options and little hope. At Scripps Research, scientists are closer than ever to understanding how these diseases harm the brain and identifying possible drugs to stop them.

“This early preclinical work may identify proteins that protect against cognitive loss. We know it’s a long path to get to a drug, but we’re creating the foundation. We know there’s an entire landscape of potential molecular interactions that maintain healthy synapses, and any of these proteins could be a drug target.”— Hollis Cline, PhD

Website

Aging: How Biomarkers Help Diagnose Dementia

Biomarkers are measurable indicators of what’s happening in your body. They can be found in blood, other body fluids, organs, and tissues, and can be used to track healthy processes, disease progression, or even responses to a medication. Biomarkers are an important part of dementia research.

Read more

Brain Health: The Benefits Of Endurance Exercise

Research: The Search For An Alzheimer’s Vaccine

Previews: New Scientist Magazine – November 6

Read more